These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34035685)

  • 21. Formulation and stability of an extemporaneously compounded oral solution of chlorpromazine HCl.
    Prohotsky DL; Juba KM; Zhao F
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):367-70. PubMed ID: 25338106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of phenylephrine hydrochloride injection in polypropylene syringes.
    Kiser TH; Oldland AR; Fish DN
    Am J Health Syst Pharm; 2007 May; 64(10):1092-5. PubMed ID: 17494910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of gabapentin in extemporaneously compounded oral suspensions.
    Friciu M; Roullin VG; Leclair G
    PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags.
    Kaushal G; Sayre BE; Prettyman T
    Am J Health Syst Pharm; 2013 May; 70(10):894-9. PubMed ID: 23640351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Stability Study of Unit-dose Vancomycin Hydrochloride Oral Solutions in Plastic Capped Oral Syringes and Plastic Sealed Dosage Cups.
    Brown S; Lewis P
    Int J Pharm Compd; 2020; 24(3):234-237. PubMed ID: 32401742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of ampicillin trihydrate suspension in amber plastic oral syringes.
    Sylvestri MF; Makoid MC
    Am J Hosp Pharm; 1986 Jun; 43(6):1496-8. PubMed ID: 3728487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Stability of Compounded Omeprazole Suspension Versus Commercial Omeprazole Kit When Stored in Oral Syringes Under Refrigerated Conditions.
    Jackson R; Lewis P; Brown SD
    J Pharm Technol; 2020 Oct; 36(5):179-186. PubMed ID: 34752549
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Moody DE; Laycock JD; Spanbauer AC; Crouch DJ; Foltz RL; Josephs JL; Amass L; Bickel WK
    J Anal Toxicol; 1997 Oct; 21(6):406-14. PubMed ID: 9323518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of an Extemporaneously Compounded Oral Suspension of Bosentan.
    Malik A; Gorman G; Coward L; Arnold JJ
    Hosp Pharm; 2016 May; 51(5):389-95. PubMed ID: 27303093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children.
    Pramann LA; Davidow LW; van Haandel L; Funk RS
    Int J Pharm Compd; 2016; 20(3):257-261. PubMed ID: 28333668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond-use date determination of buprenorphine buccal solution using a stability-indicating high-performance liquid chromatographic assay.
    Kirk LM; Brown SD
    J Feline Med Surg; 2015 Dec; 17(12):1035-40. PubMed ID: 25680734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic comparison of two buprenorphine formulations after buccal administration in healthy male cats.
    Gulledge BM; Messenger KM; Cornell KK; Lindell H; Schmiedt CW
    J Feline Med Surg; 2018 Apr; 20(4):312-318. PubMed ID: 28569590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of 5-Fluorouracil in an extemporaneously compounded ophthalmic solution.
    Fuhrman LC; Godwin DA; Davis RA
    Int J Pharm Compd; 2000; 4(4):320-3. PubMed ID: 23985397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
    McHenry AR; Wempe MF; Rice PJ
    Int J Pharm Compd; 2017; 21(3):251-254. PubMed ID: 28557788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.